EDGAR Filing Documents for 0001144204-14-006951

Form 8-K - Current report:

SEC Accession No. 0001144204-14-006951

Filing Date

2014-02-07

Accepted

2014-02-07 16:26:07

Documents

Period of Report

2014-02-06

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	v367663_8k.htm	8-K	16954
2	EXHIBIT 4.1	v367663_ex4-1.htm	EX-4.1	65027
3	EXHIBIT 4.2	v367663_ex4-2.htm	EX-4.2	18297
4	EXHIBIT 10.1	v367663_ex10-1.htm	EX-10.1	33439
5	EXHIBIT 10.2	v367663_ex10-2.htm	EX-10.2	32040
	Complete submission text file	0001144204-14-006951.txt		167103

Mailing Address 165 LUDLOW AVENUE NORTHVALE NJ 07647

Business Address 165 LUDLOW AVENUE NORTHVALE NJ 07647 2017502646

ELITE PHARMACEUTICALS INC /NV/ (Filer) CIK: 0001053369 (see all company filings)